Brian Tanquilut is ranked #851 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Brian Tanquilut

JEF

Brian Tanquilut

Q: How accurate are Brian Tanquilut's stock ratings?

About 51% of Brian's ratings were profitable over a one-year hold, with an average return of +4.1% per rating, measured by 13Foresight from historical prices.

Jefferies

Wall Street Analyst

★★★★☆

#851

on 13Foresight · ranked by our own returns

51%

Success Rate

+4.1%

Average Return

30 of 59 calls profitable · +30.0% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 51% of Brian Tanquilut's ratings turned a profit when each position was held for 1 year — averaging +4.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

47 Buy 15 Hold 0 Sell

Brian's Stock Coverage 44 ratings · 2026-09-28

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
BKD Brookdale Senior Living	Sep 17, 2026	BUY	Strong Buy +30.4% avg upside 11 analysts	$23.00 106.98% Upside	-4.0%	·
RDNT Radnet	Sep 17, 2026	BUY	Strong Buy +17.5% avg upside 11 analysts	$96.00 35.66% Upside	-7.7%	·
HCA HCA Healthcare	Sep 17, 2026	BUY	Buy -6.6% avg upside 37 analysts	$450.00 3.27% Upside	+2.2%	·
ACHC Acadia Healthcare	Sep 17, 2026	BUY	Strong Buy +59.6% avg upside 18 analysts	$40.00 42.35% Upside	-2.5%	·
AHCO AdaptHealth	Sep 15, 2026	BUY	Strong Buy +111.9% avg upside 13 analysts	$10.00 77.38% Upside	-1.2%	·
ODD ODDITY Tech Ltd. Class A	Sep 09, 2026	HOLD	Hold +4.9% avg upside 13 analysts	$18.00 3.42% Downside	+8.7%	·
HIMS Hims & Hers Health	Sep 03, 2026	HOLD	Buy -2.7% avg upside 23 analysts	$31.00 5.34% Upside	+2.8%	·
CVS CVS Health	Aug 31, 2026	BUY	Strong Buy +20.7% avg upside 39 analysts	$120.00 34.64% Upside	-5.1%	·
TDOC Teladoc	Jul 30, 2026	HOLD	Buy +375.0% avg upside 38 analysts	$8.00 31.36% Upside	-10.5%	·
GRDN Guardian Pharmacy Services, Inc. Class A	Jun 15, 2026	BUY	Strong Buy +7.6% avg upside 8 analysts	$50.00 21.33% Upside	-2.5%	·
DOCS Doximity	May 14, 2026	HOLD	Buy +36.7% avg upside 28 analysts	$19.00 27.94% Downside	+46.3%	·
SGRY Surgery Partners	May 06, 2026	BUY	Strong Buy +66.2% avg upside 18 analysts	$17.00 18.07% Upside	+0.0%	·
AVAH Aveanna Healthcare Holdings	Mar 20, 2026	BUY	Buy -10.2% avg upside 18 analysts	$10.00 19.48% Downside	+90.3%	·
CHE Chemed	Feb 26, 2026	HOLD	Buy +8.8% avg upside 6 analysts	$400.00 21.84% Downside	+29.5%	·
HQY Healthequity	Feb 19, 2026	BUY	Strong Buy +30.3% avg upside 20 analysts	$108.00 22.41% Upside	+11.9%	·
COR Cencora	Jan 22, 2026	BUY	Buy +5.0% avg upside 45 analysts	$440.00 43.43% Upside	-12.4%	·
GDRX GoodRx Holdings	Jan 22, 2026	HOLD	Buy +285.7% avg upside 28 analysts	$2.75 17.92% Downside	+28.8%	·
CAH Cardinal Health	Jan 22, 2026	BUY	Strong Buy -4.1% avg upside 30 analysts	$270.00 22.69% Upside	+7.0%	·
LMRI Lumexa Imaging Holdings, Inc.	Jan 05, 2026	BUY	Strong Buy +87.3% avg upside 9 analysts	$23.00 125.32% Upside	-39.3%	·
PNTG Pennant Group	Dec 16, 2025	BUY	Strong Buy -9.2% avg upside 9 analysts	$40.00 1.85% Downside	+37.1%	·
THC Tenet Healthcare	Oct 31, 2025	BUY	Strong Buy -7.2% avg upside 28 analysts	$250.00 3.83% Downside	+26.4%	·
MCK McKesson	Oct 13, 2025	BUY	Strong Buy -11.2% avg upside 29 analysts	$900.00 3.75% Upside	+13.1%	·
EYE National Vision Holdings	Aug 11, 2025	BUY	Strong Buy +69.6% avg upside 13 analysts	$33.00 99.62% Upside	-3.0%	·
CYH Community Health	Jul 24, 2025	HOLD	Sell +38.7% avg upside 19 analysts	$3.00 2.14% Upside	-5.9%	·
EHC Encompass Health	Jul 21, 2025	BUY	Strong Buy -5.3% avg upside 22 analysts	$130.00 5.38% Upside	+2.6%	·
ADUS Addus Homecare	Jun 01, 2025	BUY	Strong Buy +13.1% avg upside 19 analysts	$160.00 41.42% Upside	-19.6%	·
USPH US Physical Therapy	May 22, 2025	BUY	Strong Buy +9.2% avg upside 12 analysts	$110.00 29.64% Upside	-15.2%	·
OPCH Option Care Health	Apr 11, 2025	BUY	Strong Buy +27.4% avg upside 20 analysts	$40.00 73.37% Upside	-8.1%	·
BTSG BrightSpring Health Services, Inc.	Mar 06, 2025	BUY	Strong Buy +16.3% avg upside 20 analysts	$25.00 55.74% Downside	+140.8%	·
DGX Quest Diagnostics	Oct 24, 2024	BUY	Buy -21.9% avg upside 34 analysts	$175.00 25.91% Downside	+17.5%	·
AMN AMN Healthcare Services	Oct 16, 2024	HOLD	Buy +29.9% avg upside 14 analysts	$41.00 18.55% Upside	-50.9%	·
LH Labcorp Holdings	Sep 23, 2024	BUY	Strong Buy -13.2% avg upside 37 analysts	$265.00 14.52% Downside	+26.0%	·
LFST Lifestance Health Group	Mar 06, 2024	BUY	Strong Buy +2.8% avg upside 15 analysts	$9.00 23.94% Downside	+8.8%	·
MD Pediatrix Medical Group	Mar 06, 2024	HOLD	Hold -14.6% avg upside 14 analysts	$9.00 65.76% Downside	+64.0%	·
PRVA Privia Health Group	Nov 06, 2023	BUY	Strong Buy +62.2% avg upside 26 analysts	$33.00 67.43% Upside	-6.2%	·
STLN Starling Oncology Institute	Sep 21, 2023	BUY	Strong Buy +6.2% avg upside 7 analysts	$2.50 62.45% Downside	-78.5%	·
AGL Agilon Health	Mar 29, 2023	BUY	Buy -13.6% avg upside 26 analysts	$41.00 49.17% Downside	-77.2%	·
HCSG Healthcare Services	Mar 24, 2023	HOLD	Buy +17.9% avg upside 13 analysts	$14.00 33.43% Downside	-6.1%	·
HUM Humana	Nov 04, 2020	BUY	Buy +6.0% avg upside 34 analysts	$495.00 24.41% Upside	+1.0%	·
AMZN Amazon	Jun 29, 2018	HOLD	Strong Buy +205.1% avg upside 109 analysts	—	+11.4%	·
ACAD ACADIA Pharmaceuticals	Apr 26, 2016	BUY	Strong Buy +74.3% avg upside 43 analysts	$85.00 310.94% Upside	+3.2%	·
ACH Accendra Health	Feb 16, 2016	HOLD	Sell +2356.2% avg upside 17 analysts	$36.00 4984.80% Upside	-7.8%	·
CORBF Global Cord Blood	Aug 10, 2015	BUY	Strong Buy +785.0% avg upside 3 analysts	$11.00 1056.74% Upside	-25.1%	·
SBRA Sabra Healthcare REIT	May 25, 2010	BUY	Buy +1.6% avg upside 30 analysts	$11.00 44.68% Downside	-20.4%	·

🔒 39 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Brian Tanquilut — Frequently Asked Questions

How accurate are Brian Tanquilut's stock ratings?

Based on the calls 13Foresight could measure, about 51% of Brian's ratings were profitable over a one-year hold, with an average return of +4.1% per rating, or +30.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Brian ranked on 13Foresight?

Brian Tanquilut is currently ranked #851 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Brian cover?

Brian most recently has ratings on BKD, RDNT, HCA, ACHC, AHCO, ODD, HIMS, CVS, TDOC, GRDN, DOCS, SGRY and 32 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Brian Tanquilut

Rating Distribution

Welcome to 13Foresight!